相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1
Siham Ait Benichou et al.
GENE THERAPY (2022)
Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
Jorge Espinosa-Espinosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Myotonic dystrophy type 1 embryonic stem cells show decreased myogenic potential, increased CpG methylation at the DMPK locus and RNA mis-splicing
Silvie Franck et al.
BIOLOGY OPEN (2022)
Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
Sarah J. Overby et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats
Ludovic Arandel et al.
NATURE BIOMEDICAL ENGINEERING (2022)
High-throughput Imaging of CRISPR- and Recombinant Adeno-associated Virus-induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells
Daniel Allen et al.
CRISPR JOURNAL (2022)
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
Sumitava Dastidar et al.
MOLECULAR THERAPY (2022)
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene
Beatrice Cardinali et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1
Ranjan Batra et al.
NATURE BIOMEDICAL ENGINEERING (2021)
The hallmarks of myotonic dystrophy type 1 muscle dysfunction
Lauren L. Ozimski et al.
BIOLOGICAL REVIEWS (2021)
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program
Nicholas E. Johnson et al.
NEUROLOGY (2021)
Epigenetics of Myotonic Dystrophies: A Minireview
Virginia Veronica Visconti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophy
Ashish N. Rao et al.
JCI INSIGHT (2021)
Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
Matthew K. Tanner et al.
NUCLEIC ACIDS RESEARCH (2021)
Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy
Ningyan Hu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Myotonic dystrophy type 1 drug development: A pipeline toward the market
Marta Pascual-Gilabert et al.
DRUG DISCOVERY TODAY (2021)
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
Estefania Cerro-Herreros et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Modeling muscle regeneration in RNA toxicity mice
Ramesh S. Yadava et al.
HUMAN MOLECULAR GENETICS (2021)
Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1
Emma Koehorst et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle
Xiomara Fernandez-Garibay et al.
BIOFABRICATION (2021)
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
Mohammadsharif Tabebordbar et al.
CELL (2021)
A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system
Oleksandr Kondratov et al.
MOLECULAR THERAPY (2021)
The current landscape of nucleic acid therapeutics
Jayesh A. Kulkarni et al.
NATURE NANOTECHNOLOGY (2021)
Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression
Maria Sabater-Arcis et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1
Raul Ondono et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models
Vanessa C. Wheeler et al.
JOURNAL OF HUNTINGTONS DISEASE (2021)
Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA
Kevin M. Tylock et al.
JOURNAL OF GENERAL PHYSIOLOGY (2020)
The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo
Masayuki Nakamori et al.
NATURE GENETICS (2020)
Precise Targeted Cleavage of a r(CUG) Repeat Expansion in Cells by Using a Small-Molecule-Deglycobleomycin Conjugate
Alicia J. Angelbello et al.
ACS CHEMICAL BIOLOGY (2020)
Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3′UTR RNA
Ramesh S. Yadava et al.
HUMAN MOLECULAR GENETICS (2020)
miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
Maria Sabater-Arcis et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
Ang Li et al.
MOLECULAR THERAPY (2020)
Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
Miki Ikeda et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1
Jacob N. Miller et al.
NEUROLOGY-GENETICS (2020)
A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)
Joseph Horrigan et al.
PEDIATRIC NEUROLOGY (2020)
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
Andrea Lopez-Martinez et al.
GENES (2020)
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
Estefania Cerro-Herreros et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries
Ana F. Castro et al.
GENES (2020)
INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels
Eric Paul Bennett et al.
NUCLEIC ACIDS RESEARCH (2020)
Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants
Jonas Weinmann et al.
NATURE COMMUNICATIONS (2020)
Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes
Gayle Overend et al.
HUMAN MOLECULAR GENETICS (2019)
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Gregoire Cullot et al.
NATURE COMMUNICATIONS (2019)
Collateral damage and CRISPR genome editing
Mark Thomas et al.
PLOS GENETICS (2019)
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
Christine Voellenkle et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates
Michael E. Ostergaard et al.
NUCLEIC ACIDS RESEARCH (2019)
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model
Alicia J. Angelbello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1
JuYeon Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice
Mirella Lo Scrudato et al.
MOLECULAR THERAPY (2019)
Global Increase in Circular RNA Levels in Myotonic Dystrophy
Karol Czubak et al.
FRONTIERS IN GENETICS (2019)
Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient- derived cells and mice
Arnaud F. Klein et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice
Mei Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels
Kaalak Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cell-type-specific dysregulation of RNA alternative splicing in short tandem repeat mouse knockin models of myotonic dystrophy
Curtis A. Nutter et al.
GENES & DEVELOPMENT (2019)
Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
Laurene M. Andre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
Ariadna Bargiela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Predicting the mutations generated by repair of Cas9-induced double-strand breaks
Felicity Allen et al.
NATURE BIOTECHNOLOGY (2019)
Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1
Ginny R. Morriss et al.
HUMAN MOLECULAR GENETICS (2018)
Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles
Aymeric Ravel-Chapuis et al.
HUMAN MOLECULAR GENETICS (2018)
Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes
Paola Spitalieri et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
Sumitava Dastidar et al.
NUCLEIC ACIDS RESEARCH (2018)
Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)(200) expansion in the DMPK gene: CHUQi001-A
Laurie Martineau et al.
STEM CELL RESEARCH (2018)
miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models
Estefania Cerro-Herreros et al.
NATURE COMMUNICATIONS (2018)
TALEN-Induced Double-Strand Break Repair of CTG Trinucleotide Repeats
Valentine Mosbach et al.
CELL REPORTS (2018)
Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology
Carol Imbriano et al.
GENES (2018)
Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
Laurene M. Andre et al.
FRONTIERS IN NEUROLOGY (2018)
RNA-mediated therapies in myotonic dystrophy
Sarah J. Overby et al.
DRUG DISCOVERY TODAY (2018)
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9
Yanlin Wang et al.
MOLECULAR THERAPY (2018)
Circular RNAs in Muscle Function and Disease
Simona Greco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Ningyan Hu et al.
NATURE COMMUNICATIONS (2018)
Precise small-molecule recognition of a toxic CUG RNA repeat expansion
Suzanne G. Rzuczek et al.
NATURE CHEMICAL BIOLOGY (2017)
Non-AUG translation: a new start for protein synthesis in eukaryotes
Michael G. Kearse et al.
GENES & DEVELOPMENT (2017)
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy
James D. Thomas et al.
GENES & DEVELOPMENT (2017)
A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type
Fan Zhang et al.
HUMAN MOLECULAR GENETICS (2017)
Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy
Pei-Ying Wang et al.
HUMAN MOLECULAR GENETICS (2017)
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I
Marielle Brockhoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9
Belinda S. Pinto et al.
MOLECULAR CELL (2017)
CRISPR/Cas9-Induced (CTG.GAG)n, Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
Ellen L. van Agtmaal et al.
MOLECULAR THERAPY (2017)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
Laura Valentina Renna et al.
PLOS ONE (2017)
Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy
Geraldine Sicot et al.
CELL REPORTS (2017)
Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
Dominic Jauvin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients
Claudia Provenzano et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
Junko Ueki et al.
SCIENTIFIC REPORTS (2017)
Myotonic dystrophy: candidate small molecule therapeutics
Piotr Konieczny et al.
DRUG DISCOVERY TODAY (2017)
Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9
Ranjan Batra et al.
CELL (2017)
Myotonic dystrophy: approach to therapy
Charles A. Thornton et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds
Ludovic Arandel et al.
DISEASE MODELS & MECHANISMS (2017)
Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1
Alicia J. Angelbello et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy
Long M. Luu et al.
CHEMMEDCHEM (2016)
The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair
Maria Jasin et al.
DNA REPAIR (2016)
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts
Boris Pantic et al.
EXPERIMENTAL CELL RESEARCH (2016)
Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice
Samuel T. Carrell et al.
HUMAN MOLECULAR GENETICS (2016)
Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy
Yuanzheng Gao et al.
MOLECULAR THERAPY (2016)
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts
Nicholas J. Kramer et al.
SCIENCE (2016)
Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase
Cinzia Cinesi et al.
NATURE COMMUNICATIONS (2016)
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1
A. Perfetti et al.
SCIENTIFIC REPORTS (2016)
Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila
Estefania Cerro-Herreros et al.
SCIENTIFIC REPORTS (2016)
Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy
Guiying Chen et al.
SCIENTIFIC REPORTS (2016)
Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
Masayuki Nakamori et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms
Giovanni Meola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins
Eric T. Wang et al.
GENOME RESEARCH (2015)
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy
Darren R. Bisset et al.
HUMAN MOLECULAR GENETICS (2015)
Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models
Ruth B. Siboni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
RNA Structures as Mediators of Neurological Diseases and as Drug Targets
Viachaslau Bernat et al.
NEURON (2015)
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
Agnieszka Wojtkowiak-Szlachcic et al.
NUCLEIC ACIDS RESEARCH (2015)
Genome Modification Leads to Phenotype Reversal in Human Myotonic Dystrophy Type 1 Induced Pluripotent Stem Cell-Derived Neural Stem Cells
Guangbin Xia et al.
STEM CELLS (2015)
Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models
Ruth B. Siboni et al.
CELL REPORTS (2015)
Effects on Murine Behavior and Lifespan of Selectively Decreasing Expression of Mutant Huntingtin Allele by Supt4h Knockdown
Hui-Min Cheng et al.
PLOS GENETICS (2015)
Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation
Jongkyu Choi et al.
EBIOMEDICINE (2015)
Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy
Anchel González-Barriga et al.
PLoS One (2015)
Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1
Sanjay K. Pandey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines
Ami Ketley et al.
HUMAN MOLECULAR GENETICS (2014)
Programmable RNA recognition and cleavage by CRISPR/Cas9
Mitchell R. O'Connell et al.
NATURE (2014)
Highly Specific Contractions of a Single CAG/CTG Trinucleotide Repeat by TALEN in Yeast
Guy-Franck Richard et al.
PLOS ONE (2014)
Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1
Marzena Wojciechowska et al.
RNA BIOLOGY (2014)
Noncoding RNAs: Emerging Players in Muscular Dystrophies
Germana Falcone et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Reducing Levels of Toxic RNA with Small Molecules
Leslie A. Coonrod et al.
ACS CHEMICAL BIOLOGY (2013)
Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour
Oscar Hernandez-Hernandez et al.
BRAIN (2013)
Compound loss of muscleblind-like function in myotonic dystrophy
Kuang-Yung Lee et al.
EMBO MOLECULAR MEDICINE (2013)
Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients
Juan M. Fernandez-Costa et al.
HUMAN MOLECULAR GENETICS (2013)
Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice
Michael G. Poulos et al.
HUMAN MOLECULAR GENETICS (2013)
Novel Drosophila model of myotonic dystrophy type 1: phenotypic characterization and genome-wide view of altered gene expression
Lucie Picchio et al.
HUMAN MOLECULAR GENETICS (2013)
RNA Interference Targeting CUG Repeats in a Mouse Model of Myotonic Dystrophy
Krzysztof Sobczak et al.
MOLECULAR THERAPY (2013)
Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules
Jessica L. Childs-Disney et al.
NATURE COMMUNICATIONS (2013)
Systemic Delivery of a Peptide-Linked Morpholino Oligonucleotide Neutralizes Mutant RNA Toxicity in a Mouse Model of Myotonic Dystrophy
Andrew J. Leger et al.
NUCLEIC ACID THERAPEUTICS (2013)
Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
Michinori Koebis et al.
SCIENTIFIC REPORTS (2013)
Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
Anchel Gonzalez-Barriga et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Transcriptionally Repressive Chromatin Remodelling and CpG Methylation in the Presence of Expanded CTG-Repeats at the DM1 Locus
Judith Rixt Brouwer et al.
JOURNAL OF NUCLEIC ACIDS (2013)
Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA that Causes Myotonic Dystrophy Type 1
Jessica L. Childs-Disney et al.
ACS CHEMICAL BIOLOGY (2012)
Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins
Eric T. Wang et al.
CELL (2012)
Spt4 Is Selectively Required for Transcription of Extended Trinucleotide Repeats
Chia-Rung Liu et al.
CELL (2012)
Investigating the Binding Mode of an Inhibitor of the MBNL1•RNA Complex in Myotonic Dystrophy Type 1 (DM1) Leads to the Unexpected Discovery of a DNA-Selective Binder
Chun-Ho Wong et al.
CHEMBIOCHEM (2012)
GSK3β mediates muscle pathology in myotonic dystrophy
Karlie Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Targeting nuclear RNA for in vivo correction of myotonic dystrophy
Thurman M. Wheeler et al.
NATURE (2012)
RNA-guided genetic silencing systems in bacteria and archaea
Blake Wiedenheft et al.
NATURE (2012)
Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy
Konstantinos Charizanis et al.
NEURON (2012)
RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1
Johanna E. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus
Aline Huguet et al.
PLOS GENETICS (2012)
Stabilization of Expanded (CTG)•(CAG) Repeats by Antisense Oligonucleotides
Masayuki Nakamori et al.
MOLECULAR THERAPY (2011)
Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
Virginie Francois et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy
Frederique Rau et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1
Riccardo Perbellini et al.
NEUROMUSCULAR DISORDERS (2011)
Non-ATG-initiated translation directed by microsatellite expansions
Tao Zu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models
Amparo Garcia-Lopez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells
E. Loro et al.
CELL DEATH AND DIFFERENTIATION (2010)
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
Amanda J. Ward et al.
HUMAN MOLECULAR GENETICS (2010)
Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1
Misha Koshelev et al.
HUMAN MOLECULAR GENETICS (2010)
Muscleblind1, but Not Dmpk or Six5, Contributes to a Complex Phenotype of Muscular and Motivational Deficits in Mouse Models of Myotonic Dystrophy
Anna Matynia et al.
PLOS ONE (2010)
PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
Guey-Shin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Susan A. M. Mulders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Zinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cells
David Mittelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Thurman M. Wheeler et al.
SCIENCE (2009)
Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy
James P. Orengo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
Auinash Kalsotra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Correction of CIC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy
Thurman M. Wheeler et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T
M. Bryan Warf et al.
RNA (2007)
Increased steady-state in levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation
N. Muge Kuyumcu-Martinez et al.
MOLECULAR CELL (2007)
Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy
Guey-Shin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy
Mani S. Mahadevan et al.
NATURE GENETICS (2006)
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy
Rahul N. Kanadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1
Maria de Haro et al.
HUMAN MOLECULAR GENETICS (2006)
Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF
DH Cho et al.
MOLECULAR CELL (2005)
Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1
T Kimura et al.
HUMAN MOLECULAR GENETICS (2005)
Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy
TH Ho et al.
HUMAN MOLECULAR GENETICS (2005)
Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila
JM Houseley et al.
HUMAN MOLECULAR GENETICS (2005)
Chemically induced increases and decreases in the rate of expansion of a CAG•CTG triplet repeat
M Gomes-Pereira et al.
NUCLEIC ACIDS RESEARCH (2004)
A muscleblind knockout model for myotonic dystrophy
RN Kanadia et al.
SCIENCE (2003)
Mutagenic stress modulates the dynamics of CTG repeat instability associated with myotonic dystrophy type 1
E Pineiro et al.
NUCLEIC ACIDS RESEARCH (2003)
Replication inhibitors modulate instability of an expanded trinucleotide repeat at the myotonic dystrophy type 1 disease locus in human cells
Z Yang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Chemotherapeutically induced deletion of expanded triplet repeats
VI Hashem et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities
H Seznec et al.
HUMAN MOLECULAR GENETICS (2001)
Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart
ML Valencik et al.
TRANSGENIC RESEARCH (2001)
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat
A Mankodi et al.
SCIENCE (2000)
Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability
H Seznec et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
